Tacrolimus Market Report 2026

Tacrolimus Market Overview

• Tacrolimus market size has reached to $6.97 billion in 2025 • Expected to grow to $9.06 billion in 2030 at a compound annual growth rate (CAGR) of 5.2% • Growth Driver: Organ Transplantation Driving Tacrolimus Market Growth • Market Trend: Advancements In Tacrolimus Ointment Market • North America was the largest region in 2025.

What Is Covered Under Tacrolimus Market?

Tacrolimus is an immunosuppressive medication used to prevent organ rejection post-transplantation. It functions by lowering immune system activity to stop the transplanted organ from being attacked by the immune system. Tacrolimus is used to prevent transplant rejection in the case of the kidney, heart, liver, or lung. The main product types of tacrolimus are tacrolimus capsules and tablets, tacrolimus ointment, tacrolimus injection, and tacrolimus granules. Tacrolimus capsules and tablets are forms of medication that contain tacrolimus, a substance used to prevent organ rejection after transplantation. It is used for various applications include immunosuppression, dermatitis, and others for different end users, such as organ transplant centers, hospitals, clinics, and others.

What Is The Tacrolimus Market Growth Forecast?

The tacrolimus market size is expected to see strong growth in the next few years. It will grow to $9.06 billion in 2030 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to rising number of kidney and liver transplants, growing demand for cost-effective generic drugs, increasing off-label use in dermatology, advancements in immunosuppressive drug monitoring, expanding transplant programs in emerging economies. Major trends in the forecast period include rising demand for post-transplant immunosuppressive therapies, growing use of tacrolimus in dermatological applications, increasing preference for generic immunosuppressant drugs, expansion of long-term organ transplant survival rates, higher adoption of topical tacrolimus formulations.

Global Tacrolimus Market Segmentation

1) By Product Type: Tacrolimus Capsules And Tablets, Tacrolimus Injection, Tacrolimus Granules 2) By Application: Immunosuppression, Other Applications 3) By End User: Organ Transplant Centers, Hospitals, Clinics, Other End Users Subsegments: 1) By Tacrolimus Capsules And Tablets: Oral Capsules, Oral Tablets 2) By Tacrolimus Injection: Injectable Solution, Injectable Powder 3) By Tacrolimus Granules: Oral Granules (For Suspension)

What Are The Drivers Of The Tacrolimus Market?

The increase in the number of procedures for organ transplants is expected to propel the growth of the tacrolimus market going forward. Organ transplantation is the surgical replacement of a malfunctioning organ by putting an organ or tissue from the donor into another (the recipient). Organ transplantation rates are in need due to progress in medical technology, enhancements in surgical methods, heightened awareness about organ donation, and enhanced post-transplantation care. Tacrolimus helps in organ transplantation by inhibiting T-cell activation and reducing cytokine production, thereby preventing the immune system from rejecting the transplanted organ. For instance, in January 2025, according to the Organ Procurement and Transplantation Network, a US-based non-profit organization, there was a modest rise in kidney transplants, reaching 27,759 in 2024, an increase of 1.6 percent compared to 2023. In contrast, the number of heart transplants remained nearly the same, with 4,572 procedures in 2024 compared to 4,545 in 2023. Therefore, the increase in the number of procedures for organ transplants is driving the tacrolimus industry. The increasing geriatric population is expected to propel the growth of the tacrolimus market going forward. Geriatric population refers to the group of individuals who are typically aged 65 years and older, representing older adults who may have unique healthcare, social, and physiological needs associated with aging. The increasing geriatric population is primarily due to rising life expectancy, which allows more people to live longer as a result of improved healthcare, better disease management, and enhanced living conditions. The tacrolimus supports the geriatric population by modulating immune responses to prevent organ rejection and manage autoimmune conditions, addressing the increased susceptibility to immune-related complications in older adults. For instance, in July 2024, according to the UK Parliament's House of Commons Library, a UK-based government administration, in 2022, there were 12.7 million people aged 65 or older in the UK, representing 19% of the total population. This number is projected to rise to 22.1 million by 2072, accounting for 27% of the population. Therefore, the increasing geriatric population is driving the growth of the tacrolimus industry.

Key Players In The Global Tacrolimus Market

Major companies operating in the tacrolimus market are Astellas Pharma Inc, Novartis AG, Abbott Laboratories, Viatris Inc., Teva Pharmaceutical Industries Limited, Sandoz Inc, Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories Ltd., Cipla Limited, Lupin Limited, Hikma Pharmaceuticals, Biocon Ltd., Zydus Lifesciences Limited, Torrent Pharmaceuticals Limited, Alembic Pharmaceuticals Limited, Wockhardt Limited, Zhejiang Hisun Pharmaceutical Co. Ltd., Huadong Medicine Co Ltd, Glenmark Pharmaceuticals Ltd., Panacea Biotec

Global Tacrolimus Market Trends and Insights

Major companies operating in the tacrolimus market are developing advanced medications, such as tacrolimus ointments to meet the growing demand for innovative treatments for dermatological conditions while also enhancing patient care. Tacrolimus ointment is a topical treatment containing tacrolimus, an immunosuppressive agent primarily used for treating inflammatory skin conditions. For instance, in August 2023, Glenmark, an India-based pharmaceutical company, obtained approval from the United States Food and Drug Administration (US FDA) for Tacrolimus Ointment 0.03%, which is the generic counterpart of Protopic Ointment 0.03%. Glenmark Pharmaceuticals will oversee the distribution of Tacrolimus Ointment, 0.03%, within the United States. This medication is prescribed to treat moderate-to-severe atopic dermatitis, a skin condition that causes inflammation, redness, and itching.

Regional Insights

North America was the largest region in the tacrolimus market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Tacrolimus Market?

The tacrolimus market consists of sales of oral suspension, extended-release capsules, and extended-release tablets. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Tacrolimus Market Report 2026?

The tacrolimus market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the tacrolimus industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.